Management team
Mohamad Takwa, PhD
Chief Executive Officer
Karin Agerman, PhD
Chief Operations Officer
A strategic leader with a proven track record of operational excellence in the pharmaceutical industry and beyond. Holds a PhD in Molecular Neurobiology and an Executive MBA, bringing deep experience in drug discovery and technology licensing. Has managed teams and projects within Multiple Sclerosis, pain, epilepsy, Alzheimer’s disease, and gene therapy.
Henk Mouthaan
Chief Commercial Officer
A life sciences expert with a degree in Medical Biology from the University of Leiden. Brings extensive experience in multi-omics, biomarker discovery, and diagnostics, gained through senior commercial roles at Thermo Fisher Scientific and Olink Proteomics. Through a focus on bridging science and business, he has played a key role in bringing advanced technologies to market and building strong partnerships across the life science and healthcare sectors.
Banushree Kumar, PhD
Chief Technology Officer
Board of Directors
Anders Nordström, Chairman
Other current positions: Chairman of the Board at FenoMark Diagnostics, Moleculent and Offspring Biosciences AB. Partner at Colibri Ventures.
Previous positions: Executive Vice President at Pharmacia, Board Member and CFO at Phadia AB, Board Member Halo Genomics AB, VP Finance & Operations at ArthroCare International.
Simon Elsässer, PhD
Co-founder
An accomplished scientist and academic specializing in biochemistry and biophysics. An Associate Professor at Karolinska Institutet and has conducted research at renowned institutions such as Harvard University. Took advanced technology venture courses at The New York Academy of Sciences, showing his dedication in bringing solutions for technology gaps to a commercial scene and for a wider use. Co-founded Epigenica together with Mohamad.
Eva Walde
Other current positions: Board Member, Co-owner and Investor at Scale Up Life Science Invest, Board Member at FrostPharma AB, Board Member at Sedana Medical.
Previous positions: Vice President Marketing at Olink Proteomics, VP Commercial Operations International Region at Thermo Fisher Scientific, Global Brand Director at Phadia AB, Strategic Development Manager at Pfizer.
Yang Shi, PhD
Other current positions: Professor of Epigenetics at the University of Oxford
Previous positions: Professor of Cell Biology and C. H. Waddington Professor of Pediatrics at Harvard Medical School, Professor of Pediatrics at Division of Newborn Medicine at Boston Children’s Hospital, Postdoc at Princeton University.
Stina Wallmark
Other current positions: Life Sciences Investment Director at Voima Ventures
Previous positions: Digital Strategy Leader at GE Healthcare, Digital Strategy Deployment Leader at Cytiva, Investment Manager Life Sciences at Almi Invest
Allan Asp
Other current positions: Representatve Almi Invest